Experienced in WT1-Related Wilms Tumor Syndromes

Dr. James A. Wallace

Oncology | Geriatrics | Hematology
Primary Healthcare Associates Sc
19550 Governors Hwy 3300, 
Flossmoor, IL 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Primary Healthcare Associates Sc
19550 Governors Hwy 3300, 
Flossmoor, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Wallace is an Oncologist and a Geriatrics provider in Flossmoor, Illinois. Dr. Wallace is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Pancreatic Cancer, Pancreatoblastoma, and Familial Colorectal Cancer. Dr. Wallace is currently accepting new patients.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Geriatrics
Hematology
Licenses
Internal Medicine in IL
Hospital Affiliations
Ingalls Memorial Hospital
The University Of Chicago Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 13 Less Insurance Carriers -

Locations

PRIMARY HEALTHCARE ASSOCIATES SC
19550 Governors Hwy 3300, Flossmoor, IL 60422
Call: 708-915-8660
Other Locations
PRIMARY HEALTHCARE ASSOCIATES SC
1 Ingalls Dr, Harvey, IL 60426
Call: 708-333-2300
PRIMARY HEALTHCARE ASSOCIATES SC
71 W 156th St, Harvey, IL 60426
PRIMARY HEALTHCARE ASSOCIATES SC
6701 159th St, Tinley Park, IL 60477

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated With First-Line MK-3475 (Pembrolizumab)+/- Chemotherapy (Oncologist's/Patient's Choice)
Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated With First-Line MK-3475 (Pembrolizumab)+/- Chemotherapy (Oncologist's/Patient's Choice)
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Other, Drug
Study Drugs: Pembrolizumab, Pemetrexed, Carboplatin
Study Phase: Phase 2
JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: April 22, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Erlotinib
Study Phase: Phase 3
Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy
Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy
Enrollment Status: Completed
Publish Date: May 03, 2017
Intervention Type: Device
View 3 Less Clinical Trials

13 Total Publications

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Journal: JCO precision oncology
Published: October 24, 2024
View All 13 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey Sosman
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey Sosman
Hematology | Oncology
675 N Saint Clair St Ste 21-100, 
Chicago, IL 
 (25.3 miles away)
312-695-0990
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jeffrey Sosman is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Sosman is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Nephrectomy.

Ghassan Zalzaleh
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ghassan Zalzaleh
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ghassan Zalzaleh
Hematology | Oncology

Affiliated Oncologists, LLC

10604 Southwest Hwy, 
Chicago Ridge, IL 
 (12.5 miles away)
708-634-4644
Languages Spoken:
English, Arabic
See accepted insurances
Offers Telehealth

Ghassan Zalzaleh is a Hematologist and an Oncologist in Chicago Ridge, Illinois. Dr. Zalzaleh is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Severe Congenital Neutropenia, Agranulocytosis, Chronic Familial Neutropenia, and Chronic Lymphocytic Leukemia (CLL).

Michael Kahn
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael Kahn
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael Kahn
Hematology | Oncology
4405 Weaver Pkwy, 
Waterman, IL 
 (31.9 miles away)
815-759-8070
Experience:
40+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Kahn is a Hematologist and an Oncologist in Waterman, Illinois. Dr. Kahn has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Adult Soft Tissue Sarcoma, Familial Prostate Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wallace's expertise for a condition
ConditionClose
    • Distinguished
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Wallace is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Colorectal Cancer
      Dr. Wallace is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Wallace is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Wallace is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
      Dr. Wallace is
      Distinguished
      . Learn about Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
      See more Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) experts
    • Lynch Syndrome
      Dr. Wallace is
      Distinguished
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    View All 16 Distinguished Conditions
    • Advanced
    • Adult Immune Thrombocytopenia
      Dr. Wallace is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Wallace is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anemia
      Dr. Wallace is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Breast Cancer
      Dr. Wallace is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Carcinoid Syndrome
      Dr. Wallace is
      Advanced
      . Learn about Carcinoid Syndrome.
      See more Carcinoid Syndrome experts
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Wallace is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    View All 35 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Wallace is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Hepatic Porphyria (AHP)
      Dr. Wallace is
      Experienced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Adenoid Cystic Carcinoma
      Dr. Wallace is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Wallace is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Wallace is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Alveolar Soft Part Sarcoma
      Dr. Wallace is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    View All 113 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved